Defining the most appropriate primary end point in phase 2 trials of immune checkpoint inhibitors for advanced solid cancers a systematic review and meta-analysis

Georgia Ritchie, Harry Gasper, Johnathan Man, Sally Lord, Ian Marschner, Michael Friedlander, Chee Khoon Lee*

*Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    87 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Defining the most appropriate primary end point in phase 2 trials of immune checkpoint inhibitors for advanced solid cancers a systematic review and meta-analysis'. Together they form a unique fingerprint.

    Medicine & Life Sciences